CANN
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Feb 21 closing price
Capitalization
8.96M
CGC
Price
$1.63
Change
+$0.02 (+1.24%)
Updated
Feb 21 closing price
Capitalization
784.64M
96 days until earnings call
Ad is loading...

CANN vs CGC

Header iconCANN vs CGC Comparison
Open Charts CANN vs CGCBanner chart's image
TREES
Price$0.03
Change-$0.00 (-0.00%)
Volume$40.61K
Capitalization8.96M
Canopy Growth
Price$1.63
Change+$0.02 (+1.24%)
Volume$14.18M
Capitalization784.64M
CANN vs CGC Comparison Chart
Loading...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANN vs. CGC commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANN is a Hold and CGC is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CANN: $0.03 vs. CGC: $1.63)
Brand notoriety: CANN: Not notable vs. CGC: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CANN: 35% vs. CGC: 179%
Market capitalization -- CANN: $8.96M vs. CGC: $784.64M
CANN [@Pharmaceuticals: Other] is valued at $8.96M. CGC’s [@Pharmaceuticals: Other] market capitalization is $784.64M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANN’s FA Score shows that 0 FA rating(s) are green whileCGC’s FA Score has 0 green FA rating(s).

  • CANN’s FA Score: 0 green, 5 red.
  • CGC’s FA Score: 0 green, 5 red.
According to our system of comparison, CANN is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANN’s TA Score shows that 6 TA indicator(s) are bullish while CGC’s TA Score has 3 bullish TA indicator(s).

  • CANN’s TA Score: 6 bullish, 2 bearish.
  • CGC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CANN is a better buy in the short-term than CGC.

Price Growth

CANN (@Pharmaceuticals: Other) experienced а -0.07% price change this week, while CGC (@Pharmaceuticals: Other) price change was -13.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Reported Earning Dates

CANN is expected to report earnings on Apr 17, 2023.

CGC is expected to report earnings on May 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than CANN($8.96M). CANN YTD gains are higher at: 69.444 vs. CGC (-40.511). CANN has higher annual earnings (EBITDA): -6.77M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. CANN (1.46M). CANN has less debt than CGC: CANN (22.9M) vs CGC (693M). CGC has higher revenues than CANN: CGC (362M) vs CANN (15M).
CANNCGCCANN / CGC
Capitalization8.96M785M1%
EBITDA-6.77M-1.02B1%
Gain YTD69.444-40.511-171%
P/E RatioN/AN/A-
Revenue15M362M4%
Total Cash1.46M186M1%
Total Debt22.9M693M3%
FUNDAMENTALS RATINGS
CANN vs CGC: Fundamental Ratings
CANN
CGC
OUTLOOK RATING
1..100
5087
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8896
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANN's Valuation (65) in the null industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CANN's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CGC's SMR Rating (98) in the Agricultural Commodities Or Milling industry is in the same range as CANN (100) in the null industry. This means that CGC’s stock grew similarly to CANN’s over the last 12 months.

CANN's Price Growth Rating (88) in the null industry is in the same range as CGC (96) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

CANN's P/E Growth Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CANN’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANNCGC
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 18 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CANN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVPT17.69-0.34
-1.89%
AvePoint
CMC49.78-1.06
-2.08%
Commercial Metals Company
SMBK34.79-0.74
-2.08%
SmartFinancial
OXY50.42-1.67
-3.21%
Occidental Petroleum Corp
PODC2.01-0.13
-6.07%
PodcastOne

CANN and

Correlation & Price change

A.I.dvisor tells us that CANN and MEDIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANN and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANN
1D Price
Change %
CANN100%
-0.41%
MEDIF - CANN
22%
Poorly correlated
+1.78%
SFOSF - CANN
21%
Poorly correlated
N/A
CGC - CANN
20%
Poorly correlated
+1.24%
CNTMF - CANN
14%
Poorly correlated
-10.11%
CAIHF - CANN
12%
Poorly correlated
N/A
More